Table 1 Clinical profile of patients
LAP (n = 9) | OP (n = 16) | Total (n = 25) | p value | |
|---|---|---|---|---|
Gender | ||||
Male | 7 (78 %) | 11 (69 %) | 18 (72 %) | 1.00 |
Female | 2 (22 %) | 5 (31 %) | 7 (28 %) | |
Age (years) | ||||
Median (range) | 71 (61–81) | 71 (50–80) | 71 (50–81) | 0.54 |
PS | ||||
0 | 8 (89 %) | 12 (75 %) | 20 (80 %) | 0.62 |
1 or more | 1 (11 %) | 4 (25 %) | 5 (20 %) | |
BMI (kg/m2) | ||||
Median (range) | 23 (19–26) | 22 (16–27) | 22 (16–27) | 0.33 |
Comorbiditya | ||||
None | 2 (22 %) | 6 (38 %) | 8 (32 %) | 0.66 |
Cardiovascular | 5 (56 %) | 5 (31 %) | 10 (40 %) | 0.44 |
Diabetes | 2 (22 %) | 3 (19 %) | 5 (20 %) | 1.00 |
Pulmonary | 0 (0 %) | 2 (13 %) | 2 (8 %) | 0.52 |
Hepatic | 0 (0 %) | 1 (6 %) | 1 (4 %) | 1.00 |
Nephrological | 4 (44 %) | 1 (6 %) | 5 (20 %) | 0.04 |
Neurological | 2 (22 %) | 2 (13 %) | 4 (16 %) | 0.60 |
Hb (g/dL) | ||||
Median (range) | 11.4 (9.7–14.3) | 11.3 (8.4–13.8) | 11.4 (8.4–14.3) | 0.52 |
Alb (g/dL) | ||||
Median (range) | 3.5 (3.1–4.3) | 3.7 (1.9–4.2) | 3.5 (1.9–4.3) | 0.56 |
CEA (ng/mL) | ||||
Elevated | 2 (22 %) | 10 (62 %) | 12 (48 %) | 0.10 |
CA19-9 (U/mL) | ||||
Elevated | 0 (0 %) | 5 (31 %) | 5 (20 %) | 0.12 |